Medical College of Wisconsin
CTSIResearch InformaticsREDCap

New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma. Journal of Clinical Oncology February 2024;42:TPS708-TPS708

Date

02/01/2024

DOI

10.1200/JCO.2024.42.4_suppl.TPS708

Scopus ID

2-s2.0-105024695982 (requires institutional sign-in at Scopus site)   5 Citations

Author List

Aggen DH, Garcia A, Saro Suarez JM, Sauer A, Cristiani S, Brophy FE, Streets S, Norry E, Nelson AA, Kilari D, Garmezy B, Charlson JA, Zugazagoitia J, Calvo E, Moreno I, Moreno V, Hoimes CJ, Hong DS, Cervantes A

Authors

John A. Charlson MD Associate Professor in the Medicine department at Medical College of Wisconsin
Deepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin